Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Submits Application for Research License and Appoints New Member to Executive Team
Submitted application to Health Canada for license that will allow in-house research in new facility Appointed Dr. Ed Ergenzinger to…